These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 1348364)

  • 1. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.
    Godwin AK; Meister A; O'Dwyer PJ; Huang CS; Hamilton TC; Anderson ME
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):3070-4. PubMed ID: 1348364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.
    Yao KS; Godwin AK; Johnson SW; Ozols RF; O'Dwyer PJ; Hamilton TC
    Cancer Res; 1995 Oct; 55(19):4367-74. PubMed ID: 7671249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
    O'Dwyer PJ; Perez RP; Yao KS; Godwin AK; Hamilton TC
    Biochem Pharmacol; 1996 Jul; 52(1):21-7. PubMed ID: 8678904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
    Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of gamma-glutamylcysteine synthetase and glutathione S-transferase genes in cisplatin-resistant bladder cancer cells with multidrug resistance phenotype.
    Kotoh S; Naito S; Yokomizo A; Kohno K; Kuwano M; Kumazawa J
    J Urol; 1997 Mar; 157(3):1054-8. PubMed ID: 9072542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines.
    Newkirk K; Heffern J; Sloman-Moll E; Sessions RB; Rasmussen AA; Andrews PA; Cullen KJ
    Cancer Chemother Pharmacol; 1997; 40(1):75-80. PubMed ID: 9137534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of gamma-glutamylcysteine synthetase, metallothionein and topoisomerase I or II during acquisition of drug resistance to cisplatin in human ovarian cancer cells.
    Kikuchi Y; Hirata J; Yamamoto K; Ishii K; Kita T; Kudoh K; Tode T; Nagata I; Taniguchi K; Kuwano M
    Jpn J Cancer Res; 1997 Feb; 88(2):213-7. PubMed ID: 9119751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.
    Goto S; Yoshida K; Morikawa T; Urata Y; Suzuki K; Kondo T
    Cancer Res; 1995 Oct; 55(19):4297-301. PubMed ID: 7671239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of gamma-glutamyl transpeptidase mRNA by platinum complexes in a human ovarian carcinoma cell line.
    el-akawi Z; Zdanowicz J; Creaven PJ; Abu-hadid M; Perez R; Pendyala L
    Oncol Res; 1996; 8(10-11):415-23. PubMed ID: 9114434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
    Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiol-related mechanisms of resistance in a murine tumor model.
    Richardson ME; Siemann DW
    Int J Radiat Oncol Biol Phys; 1994 May; 29(2):387-92. PubMed ID: 7910817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy.
    Kawai H; Kiura K; Tabata M; Yoshino T; Takata I; Hiraki A; Chikamori K; Ueoka H; Tanimoto M; Harada M
    Lung Cancer; 2002 Mar; 35(3):305-14. PubMed ID: 11844606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in gamma-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels.
    Bailey HH; Gipp JJ; Ripple M; Wilding G; Mulcahy RT
    Cancer Res; 1992 Sep; 52(18):5115-8. PubMed ID: 1355406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced gamma-glutamylcysteine synthetase activity decreases drug-induced oxidative stress levels and cytotoxicity.
    Das GC; Bacsi A; Shrivastav M; Hazra TK; Boldogh I
    Mol Carcinog; 2006 Sep; 45(9):635-47. PubMed ID: 16491484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance.
    Kurokawa H; Ishida T; Nishio K; Arioka H; Sata M; Fukumoto H; Miura M; Saijo N
    Biochem Biophys Res Commun; 1995 Nov; 216(1):258-64. PubMed ID: 7488097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH; Lewis AD; Ehsan MN; Sikic BI
    Cancer Res; 1991 Oct; 51(19):5181-7. PubMed ID: 1717140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors.
    Ciaccio PJ; Shen H; Jaiswal AK; Lyttle MH; Tew KD
    Mol Pharmacol; 1995 Oct; 48(4):639-47. PubMed ID: 7476889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma.
    Asakura T; Imai A; Ohkubo-Uraoka N; Kuroda M; Iidaka Y; Uchida K; Shibasaki T; Ohkawa K
    Oncol Rep; 2005 Sep; 14(3):601-7. PubMed ID: 16077962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
    Oguchi H; Kikkawa F; Kojima M; Maeda O; Mizuno K; Suganuma N; Kawai M; Tomoda Y
    Anticancer Res; 1994; 14(1A):193-200. PubMed ID: 7909418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
    Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.